BaseLaunch
The platform to launch, fund and build biotech ventures
Europe’s leading biotech platform helps scientists turn discoveries into investable ventures. Access up to CHF 500k, guidance and global pharma connections.
Discover BaseLaunch
BaseLaunch is Europe’s premier platform for creating next-generation biotech companies, helping scientists and entrepreneurs turn breakthroughs into investable ventures. We bridge the gap between science and Series A — removing barriers to industry access, company creation and funding.
Gain up to CHF 500k to de-risk your science, plus expert guidance on indication strategy, company building, IP and more. With partners like AbbVie, CSL, Johnson & Johnson, Novo Nordisk, Pureos Bioventures and Roche, you’ll sharpen your positioning, attract investors and grow faster. Our 29-company portfolio has raised over CHF 800 m — proof the formula works.
Frequently Asked Questions
BaseLaunch is Europe’s leading biotech venture builder, operated by Basel Area Business & Innovation. It helps scientists and entrepreneurs build world-class biotech companies by providing funding, hands-on company-building support, and access to a network of global pharma and venture partners.
The program is open to academic founders, researchers and biotech entrepreneurs developing breakthrough therapeutics or drug-discovery platforms.
Selected ventures can receive up to CHF 500,000 as a convertible loan to advance their science, plus extensive guidance on company creation, IP, indication strategy and business development. BaseLaunch’s industry partners — including AbbVie, CSL, Johnson & Johnson, Novo Nordisk, Pureos Bioventures and Roche — provide direct expertise.
Since its inception, BaseLaunch has supported over 29 biotech companies that have collectively raised more than CHF 800 million in financing. Many have entered strategic partnerships with leading global pharmaceutical firms, underscoring the program’s effectiveness in turning cutting-edge science into investable ventures.
BaseLaunch combines funding with deep scientific and strategic expertise. Rather than following a fixed cohort model, it tailors its support to each project’s needs and stage, focusing on quality over quantity and building sustainable companies that can attract major investors.
Applications are accepted through the BaseLaunch website based on the next application deadline. Founders submit a non-confidential deck and answer questions about their technology, data and goals. The applications are reviewed after the deadline and selected projects are invited to the next step.